Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease
NCT ID: NCT05651958
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2022-02-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Effects of Lion's Breath Technique With Chest Percussion Therapy in Pneumonia Patients
NCT06319690
Combined Effects of Buteyko Breathing Technique and Chest Wall Mobilization on Pulmonary Functions and Quality of Life
NCT06537479
Effects of Breathing Exercises With and Without Inspiratory Muscle Training in COPD Patients
NCT06555445
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD
NCT06308289
Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique
NCT06332417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pranayma Breathing Technique
Pranayma Breathing Technique protocol includes 15 breaths in the morning and 15 breaths in evening for atleast weeks.
Breathing Technique
15 repeatations of Breathing in morning and evening
Conventional Treatment
Long-acting beta-2 agonist, nebulizers and long acting anti-mucosic drugs.
Nebulizer
Active Comparator: Nebulization every 3 days with the other medicine to the active comparator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nebulizer
Active Comparator: Nebulization every 3 days with the other medicine to the active comparator.
Breathing Technique
15 repeatations of Breathing in morning and evening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with diagnosed COPD.
* Moderate to severe COPD.
* Patient with productive cough and SOB.
* No surgical procedure perform.
Exclusion Criteria
* Lung cancer patient
* Patient above 70 years age.
* Patient with open wound.
* Patient with cardiovascular issues
30 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
madiha younas, MS
Role: PRINCIPAL_INVESTIGATOR
riphah internationl university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bahawal Victoria Hospital and Civil Hospital
Chak Eighty-seven -Twelve Left, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/22/0351 Amina Muqaddas
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.